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Abstract: 
Background: Endoscopic third ventriculostomy (ETV) is an accepted alternative to 
cerebro-spinal fluid(CSF) shunting in cases of obstructive hydrocephalus. The aim of this 
study is to evaluate the shunt dependency following ETV in obstructive hydrocephalus 
patients and factors influencing it. 
Methods: This was a cross-sectional study of which a total of 206 patients presenting with 
obstructive hydrocephalus that underwent ETV from 3 major centres ;. Kuala Lumpur 
General Hospital, Hospital Universiti Sains Malaysia and Sarawak General Hospital were 
studied. Successful ETV is taken as clinically no symptoms of raised intracranial pressure 
and imaging evidence of resolution of hydrocephalus(1).   
Results: Mean age of patients was 21.1 ± 22.6 years with 98 (47.6%) being paediatrics (<12 
years) and 108 (52.4%) adults (≥12 years). 63 (30.6%) were of congenital causes, 90 
(43.7%) tumoral related, 40 (19.4%) due to hemorrhage and 13 (6.3%) post-infective. Shunt 
free outcome at one month was 179 (86.9%) and 177 (85.9%) at six months. Chi-square test 
showed no statistical significance in outcome with age groups (p value = 0.629) or outcome 
with diagnosis (p value = 0.057). Univariate analysis via logistic regression showed 
significance of Liliequist membrane with odds ratio 4.375 ; 95% CI  (1.188 - 16.115), p 
value 0.027 ;  of which patients with Liliequist membrane present are 4-fold risk of failure 
and ending up with a shunt after 1month following ETV. Also noted the nature of 
fenestration with the outcome where at one month odds ratio  17.969 ; 95% CI (2.077 - 
5.957), p value 0.009 and at six months odds ratio 19.154 ; 95% CI (2.11,173.868), p value 
0.009 signifies a large fenestra with well flapping floor of the third ventricle has a 17-fold 
chance of being shunt free at one month and 19-fold chance at six months. Multivariate 
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logistic regression analysis showed significance of nature of fenestration with the outcome 
where at one month adjusted ratio 0.231  ;  95% CI (0.091-0.518), p value 0.005 and at six 
months adjusted ratio 0.241  ;  95% CI (0.092 - 0.535), p value 0.006 signifies a large 
fenestra with well flapping floor of the third ventricle has a 0.2-fold chance of being shunt 
free at one month and six months respectively. Also noted was 6 months outcome based on 
age group with adjusted ratio 0.202 ; 95% CI (0.109 - 0.206), p value 0.006 ;  of which adult 
patients have 0.2-fold chance of being shunt free at six month following endoscopic third 
ventriculostomy. 
Survival analysis using Cox regression to generate Hazard ratio  showed ETV failure at any 
point of time in this study for tumoral causes are  0.322 times less likely to fail compared to 
congenital causes ( HR 0.322 ; 95% CI  0.122 - 0.847 ; p value 0.022). 
Conclusion: ETV is a safe and effective procedure in patients with obstructive 
hydrocephalus. Patients with presence of Liliequist membrane has a higher chance of ETV 
failure and nature of the fenestra plays a vital role in outcome of ETV. Paediatric age group 
has a slightly higher chance of ETV failure. Patients with tumors predominantly pineal and 
posterior fossa tumors has a higher chance of success compared to congenital cases. 
 
Keywords: endoscopic third ventriculostomy, hydrocephalus, shunt dependency, Liliequist 
membrane 
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Abstrak: 
 
“Endoscopic third Ventriculostomy” (ETV) merupakan satu procedur untuk merawat 
masalah air otak yang bertakung yang disebabkan oleh sekatan saluran air otak. Prosedur ini 
adalah alternatif kepada prosedur shunt. Tujuan utama penyelidikan ini adalah untuk 
menganalisa kegagalan ETV and factor-faktor yang mempengaruhinya. Seramai 206 pesakit 
dari 3 buah hospital dianalisa, iaitu dari Hospital Besar Kuala Lumpur, Hospital Universiti 
Sains Malaysia and Hospital Umum Sarawak. Mean umur pesakit 21.1 ± 22.6 tahun dengan 
47.6% pediatrik  (<12 tahun) dan 52.4% dewasa  (≥12 years). 30.6% berpunca dari masalah 
kelahiran, 43.7% berkaitan dengan barah, 19.4% oleh pendarahan dan 6.3%  post-infeksi. 
Kadar kejayaan ETV pada satu bulan adalah 86.9% manakala85.9% pada enam bulan. 
Analisa univariate menggunakan  “logistic regression” menunjukkan pesakit yang 
mempunyai membran Liliequist adalah 4 kali lebih kerap untuk gagal ETV dalam satu bulan 
selepas procedur itu. Pesakit dengan lubang ETV yang besar dan mengepak dengan baik 
adalah 17 kali pada satu bulan dan 19 kali pada enam bulan lebih kerap untuk mengubati 
penakungan air otak dan tidak perlu menjalani prosedur yang lain. Manakala Analisa 
multivariate menunjukkan pesakit dengan lubang ETV yang besar dan mengepak dengan 
baik adalah 0.2 kali pada satu and enam bulan untuk mengubati penakungan air otak 
Kesimpulannya ETV merupakan satu prosedur yang selamat dan efektif  dalam mengubati 
masalah penakungan air otak disebabkan oleh sekatan aliran air otak. Pesakit yang memiliki 
membran “Liliequist” mempunyai kebarangkalian yang lebih tinggi untuk gagal prosedur 
ETV manakala sifat lubang yang dibuat dalam prosedur ETV memainkan peranan yang 
penting dalam kejayaan prosedur ETV. Pesakit kanak-kanak mempunyai kebarangkalian 
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yang lebih tinggi berbanding dewasa untuk gagal prosedur ETV. Pesakit dengan barah 
bahagian pineal and juga pangkal otak didapat mempunyai kebarangkalian yang lebih tinggi 
untuk manafaat dari ETV berbanding kes-kes masalah kelahiran. 
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Introduction – literature review and rationale for the study: 
 
Sir Walter E. Dandy is still considered as the father of neurosurgical endoscopy as he first 
described ventricular anatomy via ventriculoscopy in the early 1920s. He then went on to 
describe methods of performing third ventriculostomy first transcranially via subfrontal and 
subtemporal approaches and subsequently endoscopically along with choroid plexotomy (2). 
However it was William Mixter who first successfully performed a third ventriculostomy 
on a child using a urethroscope in 1923 (2). Scopes were then modified and redeveloped to 
modern ventriculoscopes which are used today. Treating non-communicationg 
hydrocephalus via third ventriculostomy has picked up over the recent years with the 
advancement of scopes and was not preferred in the olden days due to the high levels of 
morbidity and mortalities with cenventional scopes and instruments. 
Indications and role for endoscopic third ventriculostomy is fairly clear and is done in cases 
of obstructive hydrocephalus with imaging evidence of dilated ventricles(3). Endoscopic 
third ventriculostomy has been attempted in cases of communicating hydrocephalus such as 
idiopathic normal pressure hydrocephalus(4, 5). 
The procedure itself is fairly a straight forward procedure but requires a lot of care and 
caution. Burr hole is made over Kocher’s point either on the right or left side, dura is then 
cut and cauterised. The endoscope is introduced into the anterior horn of the lateral 
ventricle. Endoscope is then gently navigated through the foramen of Monro to visualise 
the floor of the third ventricle. The floor of the third ventricle is then fenestrated using 
cautery and this fenestra is then enlarged using a Fogarty balloon catheter. Some choose to 
cauterize the choroid plexus especially in paediatric obstructive hydrocephalus patients(6). 
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Multiple studies analysing the outcome of endoscopic third ventriculostomy has been done 
however no such study has been done in the Malaysian population. Most of the large series 
studies published are from developed countries(7). Sacko, Oumar, et al (7) reported  a large 
series 368 cases of endoscopic third ventriculostomies in France with a success rate of 
68.5%. Predorminant cause of obstructive hydrocephalus was tumors (53%), aqueductal 
stenosis (18%) and hemorrhage related (13%). Another study done in Britain, Waqar, 
Mueez, et al.(8) studied 190 cases of endoscopic third ventriculostomy for hydrocephalus 
with a success rate of 73%. The largest series publish from developing countries was the 
studies done by Benjamin Warf  in Uganda(9, 10) amongst paediatric population. Total 403 
patients underwent endoscopic third ventriculostomy with a success rate of 57% mainly 
failures were seen under the age of  6 months with cisternal scarring following hemorrhage 
or infection. 
The main aim of this study the shunt dependency outcome of endoscopic third 
ventriculostomy in managing obstructive hydrocephalus. Cases that end up with a shunt 
would be taken as failed endoscopic third ventriculostomy. We would like to delianate the 
main factors causing failure of the procedure amongst the Malaysian population. Would also 
like to evaluate shunt dependency in adults and paedatric age groups separately. 
10 
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Abstract 
 
Background: Endoscopic third ventriculostomy (ETV) is an accepted alternative to 
cerebro-spinal fluid(CSF) shunting in cases of obstructive hydrocephalus. The aim of this 
study is to evaluate the shunt dependency following ETV in obstructive hydrocephalus 
patients and factors influencing it. 
Methods: This was a cross-sectional study studying the shunt dependency outcome of ETV 
in the management of obstructive hydrocephalus. Total 206 patients presenting with 
obstructive hydrocephalus that underwent ETV from 3 major centres ; Kuala Lumpur 
General Hospital, Hospital Universiti Sains Malaysia and Sarawak General Hospital were 
studied. Successful ETV is taken as clinically no symptoms of raised intracranial pressure 
and imaging evidence of resolution of dilated ventricles(1).   
Results: Mean age of patients was 21.1 ± 22.6 years with 98 (47.6%) being paediatrics (<12 
years) and 108 (52.4%) adults (≥12 years). 30.6% were of congenital causes, 43.7% tumoral 
related, 19.4% due to hemorrhage and 6.3% post-infective. Shunt free outcome at one month 
was 179 (86.9%) and 177 (85.9%) at six months. Chi-square test showed no statistical 
significance in outcome with age groups (p value 0.629) or outcome with diagnosis (p value 
0.057). Analysis via logistic regression showed significance of Liliequist membrane with 
odds ratio 4.375 ; 95% CI (1.188 - 16.115), p value 0.027 ; of which patients with Liliequist 
membrane present are 4-fold risk of failure after 1month following ETV. Also noted the 
nature of fenestration with the outcome where at one month odds ratio  17.969 ; 95% CI 
(2.077 - 5.957), p value 0.009 and at six months odds ratio 19.154 ; 95% CI (2.11,173.868), 
p value 0.009 signifies a large fenestra with well flapping floor of the third ventricle has a 
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17-fold chance of being shunt free at 1 month and 19-fold chance at 6 months respectively. 
Multivariate logistic regression analysis showed significance of nature of fenestration with 
the outcome where at one month adjusted ratio 0.231  ;  95% CI (0.091-0.518), p value 
0.005 and at six months adjusted ratio 0.241  ;  95% CI (0.092 - 0.535), p value 0.006 
signifies a large fenestra with well flapping floor of the third ventricle has a 0.2-fold chance 
of being shunt free at one month and six months respectively. Also noted was 6 months 
outcome based on age group with adjusted ratio 0.202 ; 95% CI (0.109 - 0.206), p value 
0.006 ;  of which adult patients have 0.2-fold chance of being shunt free at six month 
following endoscopic third ventriculostomy. 
Survival analysis using Cox regression to generate Hazard ratio  showed ETV failure at any 
point of time in this study for tumoral causes are  0.322 times less likely to fail compared to 
congenital causes ( HR 0.322 ; 95% CI  0.122 - 0.847 ; p value 0.022). 
Conclusion: ETV is a safe and effective procedure in patients with obstructive 
hydrocephalus. Patients with presence of Liliequist membrane has a higher chance of ETV 
failure and nature of the fenestra plays a vital role in outcome of ETV. Paediatric age group 
has a slightly higher chance of ETV failure. Patients with tumors predominantly pineal and 
posterior fossa tumors has a higher chance of success compared to congenital cases. 
Survival analysis using cox regression to generate Hazard ratio showed endoscopic third 
ventriculostomy failure at any point of time in this study for tumoral causes are  0.322 times 
less likely compared to congenital causes ( HR 0.322 ; 95% CI  0.122 - 0.847 ; p value 
0.022). 
Keywords: endoscopic third ventriculostomy, obstructive hydrocephalus, shunt dependency  
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1 Introduction 
Ventriculo-peritoneal shunting has been the gold standard treatment for obstructive 
hydrocephalus since it was developed by Nulsen and Spitz in 1951. Sir Walter E. Dandy 
pioneered ventricular visualisation in the early 1920s using a cystoscope. He then went on to 
describe methods of performing third ventriculostomy first transcranially via subfrontal and 
subtemporal approaches and subsequently endoscopically along with choroid plexotomy. 
However William Mixter was the first to successfully fenestrate the floor of the third 
ventricle endoscopically in attempt to treat obstructive hydrocephalus in 1923(2). Shunts then 
superseded ventriculotomies as the morbidity and mortality rates were much higher back 
then with the conventional scopes. Only over the recent decade that endoscopic third 
ventriculostomy has started to pick up. Mainly due to the advances in endoscopes and also 
extensive trials and studies have been carried out on the role of endoscopic third 
ventriculostomy in the management of obstructive hydrocephalus. However in developing 
countries endoscopic third ventriculostomy is very slowly picking up and way outnumbered 
in comparison to shunts.  Majority of the data published so far are mainly from developed 
countries and very few from developing countries. No such data has been published from 
Malaysia so far. 
Indications and role for endoscopic third ventriculostomy is fairly clear and is done in cases 
of obstructive hydrocephalus with imaging evidence of dilated ventricles(3). Endoscopic 
third ventriculostomy has been attempted in cases of communicating hydrocephalus such as 
idiopathic normal pressure hydrocephalus(4, 5). 
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The procedure itself is fairly a straight forward procedure but requires a lot of care and 
caution. Burr hole is made over Kocher’s point either on the right or left side, dura is then 
cut and cauterised. The endoscope is introduced into the anterior horn of the lateral 
ventricle. Endoscope is then gently navigated through the foramen of Monro to visualise the 
floor of the third ventricle. The floor of the third ventricle is then fenestrated using cautery 
(monopolar, bipolar or laser) and this fenestra is then enlarged using a Fogarty balloon 
catheter (3 or 4 Fr). In some cases there is the presence of an extra membrane known as the 
Liliequist membrane which has to fenestrated also. A good flapping floor of the third 
ventricle indicates a good fenestration. Care is to be taken not damage vital surrounding 
structures such as hypothalamus, mamillary body and vascular structures such as anterior 
septal vein, thalamostriate vein and basilar artery. 
 
2 Materials and Methods 
2.1 Patients 
This was a cross-sectional study studying the shunt dependency outcome of endoscopic third 
ventriculostomy in the management of obstructive hydrocephalus. All patients presenting 
with obstructive hydrocephalus that underwent endoscopic third ventriculostomy was 
included in this study and patients who had previous cerebro-spinal fluid (CSF) diversions 
or prior endoscopic third ventriculostomies were excluded. All causes of obstructive 
hydrocephalus were taken into account. Diagnosis of obstructive hydrocephalus is 
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confirmed with computed tomography and magnetic resonance imaging evidence of dilated 
ventricles.  For purposes of this study the causes of obstructive hydrocephalus was broadly 
put into 4 different groups ie. congenital, tumoral, hemorrhage and post-infective causes. All 
patients were evaluated clinically and with imaging immediate post-operatively, at one 
month and six months post- endoscopic third ventriculostomy. Successful endoscopic third 
ventriculostomy is taken as clinically no symptoms of raised intracranial pressure and 
imaging evidence of resolution of dilated ventricles(1). Data was collected from 3 major 
centres; Kuala Lumpur General Hospital, Hospital Universiti Sains Malaysia and Sarawak 
General Hospital. 
2.2 Statistical methods 
The data was analyzed using commercially available IBM Statistical Packages for Social 
Sciences (SPSS) statistics for windows version 20. All variables were expressed as mean ± 
standard deviation (X ± SD). Chi-square, logistic regression univariate and multivariate 
analysis and survival analysis using Cox regression to generate Hazard ratio; analysis was 
used to study correlations of the investigated parameters (significance was assumed at a level 
of p-value < 0.05). [National Medical Research Register (NMRR), www.nmrr.gov.my, 
Identifier: NMRR-15-1145-24949]. 
3 Results 
Total 206 patients with obstructive hydrocephalus undergoing ETV only once were studied. 
Mean age of patients was 21.1 ± 22.6 years with 98 (47.6%) being paediatrics (<12 years) 
and 108 (52.4%) adults (≥12 years). 63 (30.6%) were of congenital causes, 90 (43.7%) 
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tumoral related, 40 (19.4%) due to hemorrhage and 13 (6.3%) post-infective. Shunt free 
outcome at one month was 179 (86.9%) and 177 (85.9%) at six months (Table 1).  
Chi-square test showed no statistical significance in outcome with age groups (p value = 
0.629) or outcome with diagnosis (p value = 0.057).  
Univariate analysis via logistic regression showed significance of Liliequist membrane with 
odds ratio 4.375 ; 95% CI  (1.188 - 16.115), p value 0.027 ;  of which patients with 
Liliequist membrane present are 4-fold risk of failure and ending up with a shunt after 
1month following endoscopic third ventriculostomy. Also noted the nature of fenestration 
with the outcome where at one month odds ratio  17.969  ;  95% CI (2.077 - 5.957), p value 
0.009 and at six months odds ratio 19.154  ;  95% CI (2.11,173.868), p value 0.009 signifies 
a large fenestra with well flapping floor of the third ventricle has a 17-fold chance of being 
shunt free at one month and 19-fold chance at six months respectively. (Table 2). 
Multivariate logistic regression analysis showed significance of nature of fenestration with 
the outcome where at one month adjusted ratio 0.231  ;  95% CI (0.091-0.518), p value 
0.005 and at six months adjusted ratio 0.241  ;  95% CI (0.092 - 0.535), p value 0.006 
signifies a large fenestra with well flapping floor of the third ventricle has a 0.2-fold chance 
of being shunt free at one month and six months respectively. Also noted was age at 6 
months with adjusted ratio 0.202 ; 95% CI (0.109 - 0.206), p value 0.006 ;  of which adults 
patients have 0.2-fold chance of being shunt free at six month following endoscopic third 
ventriculostomy. (Table 3). 
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Survival analysis using cox regression to generate Hazard ratio (Table 4)  showed 
endoscopic third ventriculostomy failure at any point of time in this study for tumoral causes 
are  0.322 times less likely compared to congenital causes ( HR 0.322 ; 95% CI  0.122 - 
0.847 ; p value 0.022). 
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Table 1 Demographic variables with outcome at one and six month intervals 
Variables 
No of 
patients  
(%) 
Success (%) Failure (%) 
1 month 6 months 1 month 6 months 
 
Mean age in years 
       
        21.1  ( Paediatric 2.4 years and Adults 37.1) 
Paediatric ( < 12yrs) 
Adults ( ≥12 yrs) 
 98(47.6%) 
108(52.4%) 
83(84.7%) 
96(88.9%) 
83(84.7%) 
94(87.0%) 
15(15.3%) 
12(11.1%) 
15(15.3%) 
14(13.0%) 
Sex 
Male 
Female 
 
117(56.8%) 
89(43.2%) 
 
102(57.0%) 
77(43.0%) 
 
102(57.6%) 
75(42.4%) 
 
15(55.6%) 
12(44.4%) 
 
15(51.7%) 
14(48.3%) 
Diagnosis 
Congenital 
Tumoral 
Hemorrhage 
Infection 
 
63(30.6%) 
90(43.7%) 
40(19.4%) 
13(6.3%) 
 
50(27.9%) 
86(48.0%) 
32(17.9%) 
11(6.1%) 
 
50(28.2%) 
84(47.5%) 
32(18.1%) 
11(6.2%) 
 
13(48.1%) 
4(14.8%) 
8(29.6%) 
2(7.4%) 
 
13(44.8%) 
6(20.7%) 
8(27.6%) 
2(6.9%) 
Operation done 
ETV 
ETV & biopsy 
ETV & washout 
ETV & fenestration 
 
96(46.6%) 
61(29.6%) 
41(19.9%) 
8(3.9%) 
 
82(45.8%) 
57(31.8%) 
32(17.9%) 
8(4.5%) 
 
80(45.2%) 
57(32.2%) 
32(18.1%) 
8(4.5%) 
 
14(51.9%) 
4(14.8%) 
9(33.3% 
0 
 
16(55.2%) 
4(13.8%) 
9(31.0%) 
0 
Scope degree 
Zero degree 
Thirty degree 
 
169(82.0%) 
37(18.0%) 
 
147(82.1%) 
32(17.9%) 
 
145(81.9%) 
32(18.1%) 
 
22(81.5%) 
5(18.5%) 
 
24(82.8%) 
5(17.2%) 
CSF nature 
Clear 
Blood stained 
Turbid 
Xanthochromic 
 
158(76.7%) 
38(18.4%) 
2(1.0%) 
8(3.9%) 
 
143(79.9%) 
30(16.8%) 
0 
6(3.4%) 
 
141(79.7%) 
30(16.9%) 
0 
6(3.4%) 
 
15(55.6%) 
8(29.6%) 
2(7.4%) 
2(7.4%) 
 
17(58.6%) 
8(27.6%) 
2(6.9%) 
2(6.9%) 
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Table 1 continued 
Variables 
No of 
patients  
(%) 
Success (%) Failure (%) 
1 month 6 months 1 month 6 months 
Choroid plexus 
Normal 
Abnormal 
 
201(97.6%) 
5(2.4%) 
 
174(97.2%) 
5(2.8%) 
 
172(97.2%) 
5(2.8%) 
 
27(100%) 
0 
 
29(100%) 
0 
Anterior  Septal Vein 
Normal 
Abnormal 
 
205(99.5%) 
1(0.5%) 
 
178(99.4%) 
1(0.6%) 
 
176(99.4%) 
1(0.6%) 
 
27(100%) 
0 
 
27(100%) 
0 
Thalamostriate Vein 
Normal 
Abnormal 
 
205(99.5%) 
1(0.5%) 
 
178(99.4%) 
1(0.6%) 
 
176(99.4%) 
1(0.6%) 
 
27(100%) 
0 
 
29(100%) 
0 
Third Ventricle Floor 
Thin & Bulging 
Thick & Bulging 
Thin & not bulging 
Thick & not bulging 
 
140(68.0%) 
15(7.3%) 
47(22.8%) 
4(1.9%) 
 
122(68.2%) 
12(6.7%) 
41(22.9%) 
4(2.2%) 
 
120(67.8%) 
12(6.8%) 
41(23.2%) 
4(2.3%) 
 
18(66.7%) 
3(11.1%) 
6(22.2%) 
0 
 
20(69.0%) 
3(10.3%) 
6(20.7%) 
0 
Infundibular recess 
Normal 
Abnormal 
 
200(97.1%) 
6(2.9%) 
 
173(96.6%) 
6(3.4%) 
 
171(96.6%) 
6(3.4%) 
 
27(100%) 
0 
 
29(100%) 
0 
Mamillary body 
Normal 
Abnormal 
 
202(98.1%) 
4(1.9%) 
 
175(97.8%) 
4(2.2%) 
 
173(97.7%) 
4(2.3%) 
 
27(100%) 
0 
 
29(100%) 
0 
Fogarty catheter size 
3 Fr 
4 Fr 
 
178(86.4%) 
28(13.6%) 
 
155(86.6%) 
24(13.4%) 
 
153(86.4%) 
24(13.6%) 
 
23(85.2%) 
4(14.8%) 
 
25(86.2%) 
4(13.8%) 
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Table 1 continued 
Variables 
No of 
patients  
(%) 
Success (%) Failure (%) 
1 month 6 months 1 month 6 months 
Cauterization 
Monopolar 
Bipolar 
Laser 
 
44(21.4%) 
161(78.2%) 
1(0.5%) 
 
39(21.8%) 
139(77.7%) 
1(0.6%) 
 
39(22.0%) 
137(77.4%) 
1(0.6%) 
 
5 (18.5%) 
22(81.5%) 
0 
 
5(17.2%) 
24(82.8%) 
0 
Fenestration attempts 
Once 
More than once 
 
180(87.4%) 
26(12.6%) 
 
157(87.7%) 
22(12.3%) 
 
155(87.6%) 
22(12.4%) 
 
23(85.2%) 
4(14.8%) 
 
25(86.2%) 
4(13.8%) 
Liliequist membrane 
Absent 
Present 
 
118(57.3%) 
88(42.7%) 
 
108(60.3%) 
71(39.7%) 
 
106(59.9%) 
71(40.1%) 
 
10(37.0%) 
17(63.0%) 
 
12(41.4%) 
17(58.6%) 
Nature of fenestration 
Flapping well with 
large stoma 
Flapping well with 
small stoma 
Flapping poorly 
 
198(96.1%) 
 
6(2.9%) 
 
2(1.0%) 
 
175(97.8%) 
 
4(2.2%) 
 
0 
 
173(97.7%) 
 
4(2.3%) 
 
0 
 
23(85.2%) 
 
2(7.4%) 
 
2(7.4%) 
 
25(86.2%) 
 
2(6.9%) 
 
2(6.9%) 
 
Outcome 
 
206(100%) 
 
179(86.9%) 
 
177(85.9%) 
 
27(13.1%) 
 
29(14.1%) 
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Table 2 Logistic regression (Odds ratio- OR) at one and six month intervals 
 
 
At One Month At Six Months 
ß(S.E.) OR (95% CI) P ß(S.E.) OR (95% CI) P 
Age 0.024(0.016) 1.025(0.994,1.057) 0.121 0.038(0.015) 1.039(1.008,1.07) 0.012 
Sex 0.352(0.554) 1.422(0.48,4.212) 0.525 0.586(0.546) 1.796(0.615,5.242) 0.284 
Diagnosis -0.294(0.522) 0.745(0.268,2.072) 0.573 -0.296(0.524) 0.744(0.266,2.077) 0.572 
Operation done 0.249(0.572) 1.283(0.418,3.935) 0.663 -0.058 (0.607) 0.944(0.287,3.104) 0.924 
Scope Brand 2.114(1.734) 8.278(0.277,247.627) 0.223 2.231(1.697) 9.311(0.335,259.116) 0.189 
Scope Degree -0.627(1.125) 0.534(0.059,4.845) 0.577 -0.716(1.136) 0.489(0.053,4.527) 0.528 
CSF nature 0.193(0.331) 1.212(0.633,2.321) 0.561 0.165(0.339) 1.179(0.606,2.294) 0.627 
Choroid Plexus -16.433(19995.745) 0 0.999 -16.291(19959.214) 0 0.999 
Anterior Septal Vein 32.649(52052.415) 1.51x10¹⁴ (0) 0.999 32.877(52041.574) 1.90x10¹⁴ (0) 0.999 
3rd Ventricular Floor -0.339(0.312) 0.713(0.386,1.314) 0.278 -0.339(0.307) 0.712(0.391,1.299) 0.269 
Infundibular Recess -17.611(16717.365) 0 0.999 -17.869(16652.35) 0 0.999 
Mamillary Body -17.991(20363.8) 0 0.999 -18.461(20424.957) 0 0.999 
Fogarty catheter size -0.912(1.159) 0.402(0.041,3.898) 0.432 -1.17(1.207) 0.31(0.029,3.303) 0.332 
Cauterization 1.715(1.466) 5.558(0.314,98.287) 0.242 1.895(1.443) 6.651(0.393,112.614) 0.189 
Fenestration Attempts 0.608(1.059) 1.837(0.231,14.644) 0.566 0.519(1.061) 1.68(0.21,13.428) 0.625 
Liliequist Membrane 1.476(0.665) 4.375(1.188,16.115) 0.027 1.174(0.63) 3.234(0.941,11.12) 0.063 
Nature Of Fenestration 2.889(1.101) 17.969(2.077,5.957) 0.009 2.952(1.125) 19.154(2.11,173.868) 0.009 
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Table 3 Multivariate Logistic regression (Adjusted ratio- AR) at one and six month intervals 
 
 
At One Month At Six Months 
ß(S.E.) AR (95% CI) P ß(S.E.) AR (95% CI) P 
Age 0.002(0.001) 0.114(-0.001-0.116) 0.211 0.03(0.001) 0.202(0.109-0.206) 0.006 
Cauterization 0.171(0.389) 0.035(-0.595-0.937) 0.708 0.160(0.403) 0.032(-0.635-0.954) 0.692 
Liliequist Membrane 0.094(0.048) 0.138(0.000-0.188) 0.050 0.073(0.050) 0.104(-0.024-0.171) 0.141 
Nature Of Fenestration 0.304(0.108) 0.231(0.091-0.518) 0.005 0.327(0.113) 0.241(0.092-0.535) 0.006 
  
Table 4 Survival analysis using Cox regression to generate hazard ratio (HR) 
 ß(S.E.) HR (95% CI) P 
Congenital 0 1 0.114 
Tumor -1.134 (0.494) 0.322 (0.122 , 0.847) 0.022 
Hemorrhage -0.011 (0.449) 0.989 (0.410 , 2.387) 0.981 
Infection -0.232 (0.760) 0.793 (0.179 , 3.514) 0.760 
